These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 16874861)
1. Mechanism for Src activation by the CCK2 receptor: Patho-physiological functions of this receptor in pancreas. Ferrand A; Vatinel S; Kowalski-Chauvel A; Bertrand C; Escrieut C; Fourmy D; Dufresne M; Seva C World J Gastroenterol; 2006 Jul; 12(28):4498-503. PubMed ID: 16874861 [TBL] [Abstract][Full Text] [Related]
2. A novel mechanism for JAK2 activation by a G protein-coupled receptor, the CCK2R: implication of this signaling pathway in pancreatic tumor models. Ferrand A; Kowalski-Chauvel A; Bertrand C; Escrieut C; Mathieu A; Portolan G; Pradayrol L; Fourmy D; Dufresne M; Seva C J Biol Chem; 2005 Mar; 280(11):10710-5. PubMed ID: 15640156 [TBL] [Abstract][Full Text] [Related]
3. αv integrin: a new gastrin target in human pancreatic cancer cells. Cayrol C; Bertrand C; Kowalski-Chauvel A; Daulhac L; Cohen-Jonathan-Moyal E; Ferrand A; Seva C World J Gastroenterol; 2011 Oct; 17(40):4488-95. PubMed ID: 22110279 [TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells. Cayrol C; Clerc P; Bertrand C; Gigoux V; Portolan G; Fourmy D; Dufresne M; Seva C Oncogene; 2006 Jul; 25(32):4421-8. PubMed ID: 16547500 [TBL] [Abstract][Full Text] [Related]
6. An ITIM-like motif within the CCK2 receptor sequence required for interaction with SHP-2 and the activation of the AKT pathway. Vatinel S; Ferrand A; Lopez F; Kowalski-Chauvel A; Estève JP; Fourmy D; Dufresne M; Seva C Biochim Biophys Acta; 2006 Oct; 1763(10):1098-107. PubMed ID: 16963136 [TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of CCK2 receptors sensitizes murine pancreatic acinar cells to carcinogen-induced preneoplastic lesions formation. Mathieu A; Clerc P; Portolan G; Bierkamp C; Lulka H; Pradayrol L; Seva C; Fourmy D; Dufresne M Int J Cancer; 2005 May; 115(1):46-54. PubMed ID: 15688412 [TBL] [Abstract][Full Text] [Related]
9. Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors. Sanchez C; Escrieut C; Clerc P; Gigoux V; Waser B; Reubi JC; Fourmy D Mol Cell Endocrinol; 2012 Feb; 349(2):170-9. PubMed ID: 22040601 [TBL] [Abstract][Full Text] [Related]
10. Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo. Bierkamp C; Bonhoure S; Mathieu A; Clerc P; Fourmy D; Pradayrol L; Seva C; Dufresne M Am J Pathol; 2004 Dec; 165(6):2135-45. PubMed ID: 15579455 [TBL] [Abstract][Full Text] [Related]
11. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907 [TBL] [Abstract][Full Text] [Related]
12. Arrestin serves as a molecular switch, linking endogenous alpha2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. Wang Q; Lu R; Zhao J; Limbird LE J Biol Chem; 2006 Sep; 281(36):25948-55. PubMed ID: 16809338 [TBL] [Abstract][Full Text] [Related]
13. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells. Masamune A; Satoh M; Kikuta K; Suzuki N; Shimosegawa T World J Gastroenterol; 2005 Jun; 11(22):3385-91. PubMed ID: 15948243 [TBL] [Abstract][Full Text] [Related]
14. Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia. Clerc P; Leung-Theung-Long S; Wang TC; Dockray GJ; Bouisson M; Delisle MB; Vaysse N; Pradayrol L; Fourmy D; Dufresne M Gastroenterology; 2002 Feb; 122(2):428-37. PubMed ID: 11832457 [TBL] [Abstract][Full Text] [Related]
15. CCK1 and CCK2 receptors are expressed on pancreatic stellate cells and induce collagen production. Berna MJ; Seiz O; Nast JF; Benten D; Bläker M; Koch J; Lohse AW; Pace A J Biol Chem; 2010 Dec; 285(50):38905-14. PubMed ID: 20843811 [TBL] [Abstract][Full Text] [Related]
16. Calmodulin mediates Fas-induced FADD-independent survival signaling in pancreatic cancer cells via activation of Src-extracellular signal-regulated kinase (ERK). Yuan K; Jing G; Chen J; Liu H; Zhang K; Li Y; Wu H; McDonald JM; Chen Y J Biol Chem; 2011 Jul; 286(28):24776-84. PubMed ID: 21613217 [TBL] [Abstract][Full Text] [Related]
17. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo. Gomes EG; Connelly SF; Summy JM Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399 [TBL] [Abstract][Full Text] [Related]
19. NHERF2 increases platelet-derived growth factor-induced proliferation through PI-3-kinase/Akt-, ERK-, and Src family kinase-dependent pathway. Jung Kang Y; Su Jeon E; Jin Lee H; Oh YS; Suh PG; Sup Jung J; Donowitz M; Ho Kim J Cell Signal; 2004 Jul; 16(7):791-800. PubMed ID: 15115658 [TBL] [Abstract][Full Text] [Related]
20. Valine-286 residue in the third intracellular loop of the cholecystokinin 2 receptor exerts a pivotal role in cholecystokinin 2 receptor mediated intracellular signal transduction in human colon cancer cells. Yu HG; Schäfer H; Mergler S; Müerköster S; Cramer T; Höcker M; Herzig KH; Schmidt WE; Schmitz F Cell Signal; 2005 Dec; 17(12):1505-15. PubMed ID: 15951156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]